Pharmacokinetic, Safety and Immunogenicity Study of CMAB809 and Herceptin in Healthy Volunteers

NCT04049409 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: CMAB809
DRUG: Trastuzumab

Sponsor

Taizhou Mabtech Pharmaceutical Co.,Ltd